Serum Institute of India

The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration

A writ petition has been filed at the Supreme Court seeking an order from the court to make the second dose of COVID vaccines for the 13.5 lakh elderly people

The new vaccine is being developed in partnership with American vaccine developer Novavax

The government is to provide the AstraZeneca COVID-19 vaccine as an alternative to the booster dose of the Covishield vaccine.

Serum Institute on Tuesday said it hopes to start delivering vaccines to the UN-backed COVAX and to other countries by the end of the year.

As many as 50 employees of Bharat Biotech, an Indian COVID-19 manufacturing company, tested positive for the virus, a senior executive confirmed on Thursday.

Since India opened vaccinations to all adults this month the pace of administering the shots has dropped with states saying they only have limited stock to give out.

Bangladesh's health experts warn of imminent vaccine shortages just as the country should be stepping up jabs and as more contagious virus variants are beginning to be detected.

India's COVID-19 tally reached 21,892,676 on Saturday as 401,078 new cases were registered across the country in the past 24 hours, said the federal health ministry.

Adar Poonawalla, CEO of Serum Institute of India, on Saturday night said that the production of COVID-19 vaccine Covishield is in full swing in Pune.